The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Kewal K. Jain

Jain PharmaBiotech


Blaesiring 7



Name/email consistency: high



  • Jain PharmaBiotech, Biotechnology, Blaesiring 7, Basel. 2012
  • Jain PharmaBiotech, Basel, Switzerland. 2004 - 2010


  1. Advances in use of functionalized carbon nanotubes for drug design and discovery. Jain, K.K. Expert. Opin. Drug. Discov (2012) [Pubmed]
  2. Personalized cancer vaccines. Jain, K.K. Expert. Opin. Biol. Ther (2010) [Pubmed]
  3. Cell therapy for CNS trauma. Jain, K.K. Mol. Biotechnol. (2009) [Pubmed]
  4. Personalized clinical laboratory diagnostics. Jain, K.K. Adv. Clin. Chem (2009) [Pubmed]
  5. The role of nanobiotechnology in drug discovery. Jain, K.K. Adv. Exp. Med. Biol. (2009) [Pubmed]
  6. Gene therapy for pain. Jain, K.K. Expert. Opin. Biol. Ther (2008) [Pubmed]
  7. Cell therapy for pain. Jain, K.K. Expert. Opin. Biol. Ther (2008) [Pubmed]
  8. Pain management--Visiongain's fourth annual conference. Exploring recent developments in pain therapy. Jain, K. IDrugs (2008) [Pubmed]
  9. Recent advances in nanooncology. Jain, K.K. Technol. Cancer Res. Treat. (2008) [Pubmed]
  10. Stability and delivery of RNA via the gastrointestinal tract. Jain, K.K. Current. Drug. Delivery (2008) [Pubmed]
  11. Nanomedicine: application of nanobiotechnology in medical practice. Jain, K.K. Med. Princ. Pract (2008) [Pubmed]
  12. Neuroprotection in traumatic brain injury. Jain, K.K. Drug Discov. Today (2008) [Pubmed]
  13. Current challenges and future prospects in management of neuropathic pain. Jain, K.K. Expert. Rev. Neurother (2008) [Pubmed]
  14. Innovations, challenges and future prospects of oncoproteomics. Jain, K.K. Mol. Oncol (2008) [Pubmed]
  15. Nanobiotechnology-based drug delivery to the central nervous system. Jain, K.K. Neurodegener. Dis (2007) [Pubmed]
  16. Use of nanoparticles for drug delivery in glioblastoma multiforme. Jain, K.K. Expert. Rev. Neurother (2007) [Pubmed]
  17. Applications of nanobiotechnology in clinical diagnostics. Jain, K.K. Clin. Chem. (2007) [Pubmed]
  18. Recent advances in clinical oncoproteomics. Jain, K.K. J. BUON (2007) [Pubmed]
  19. Cancer biomarkers: current issues and future directions. Jain, K.K. Curr. Opin. Mol. Ther. (2007) [Pubmed]
  20. Nanoparticles as targeting ligands. Jain, K.K. Trends Biotechnol. (2006) [Pubmed]
  21. Future prospects for the cure of brain cancer. Jain, K.K. Technol. Cancer Res. Treat. (2006) [Pubmed]
  22. Commercial potential of RNAi. Jain, K.K. Mol. Biosyst (2006) [Pubmed]
  23. Challenges of drug discovery for personalized medicine. Jain, K.K. Curr. Opin. Mol. Ther. (2006) [Pubmed]
  24. Ethical and regulatory aspects of embryonic stem cell research. Jain, K.K. Expert. Opin. Biol. Ther (2005) [Pubmed]
  25. Nanotechnology in clinical laboratory diagnostics. Jain, K.K. Clin. Chim. Acta (2005) [Pubmed]
  26. Nanotechnology-based drug delivery for cancer. Jain, K.K. Technol. Cancer Res. Treat. (2005) [Pubmed]
  27. Personalised medicine for cancer: from drug development into clinical practice. Jain, K.K. Expert. Opin. Pharmacother (2005) [Pubmed]
  28. The role of nanobiotechnology in drug discovery. Jain, K.K. Drug Discov. Today (2005) [Pubmed]
  29. IBC's 4th Annual Conference on Molecular Diagnostics. September 13-14, 2005, Convention and Expo Center, Boston, MA, USA. Jain, K.K. Expert Rev. Mol. Diagn. (2005) [Pubmed]
  30. Applications of AmpliChip CYP450. Jain, K.K. Mol. Diagn. (2005) [Pubmed]
  31. Role of nanobiotechnology in developing personalized medicine for cancer. Jain, K.K. Technol. Cancer Res. Treat. (2005) [Pubmed]
  32. Applications and commercial potential of RNAi. Jain, K.K. IDrugs (2005) [Pubmed]
  33. Proteomics and drug discovery. Jain, K.K. Contrib. Nephrol (2004) [Pubmed]
  34. Modulators of nicotinic acetylcholine receptors as analgesics. Jain, K.K. Curr. Opin. Investig. Drugs (2004) [Pubmed]
  35. RNAi and siRNA in target validation. Jain, K.K. Drug Discov. Today (2004) [Pubmed]
  36. RNAi and siRNA. Jain, K.K. Pharmacogenomics (2004) [Pubmed]
  37. Role of pharmacoproteomics in the development of personalized medicine. Jain, K.K. Pharmacogenomics (2004) [Pubmed]
  38. Applications of biochips: from diagnostics to personalized medicine. Jain, K.K. Curr. Opin. Drug. Discov. Devel (2004) [Pubmed]
  39. Current status of fluorescent in-situ hybridisation. Jain, K.K. Med. Device. Technol (2004) [Pubmed]
  40. Lab-on-a-chip and microarrays: discovery and development. Jain, K.K. Pharmacogenomics (2003) [Pubmed]
  41. Nanodiagnostics: application of nanotechnology in molecular diagnostics. Jain, K.K. Expert Rev. Mol. Diagn. (2003) [Pubmed]
  42. Current status of molecular biosensors. Jain, K.K. Med. Device. Technol (2003) [Pubmed]
  43. Proteomics and protein arrays Europa. Jain, K.K. Pharmacogenomics (2003) [Pubmed]
  44. Information on commercial aspects of pharmacogenomics. Jain, K.K. Pharmacogenomics (2003) [Pubmed]
  45. Post-genomic applications of lab-on-a-chip and microarrays. Jain, K.K. Trends Biotechnol. (2002) [Pubmed]
  46. Using proteomics to identify targets and validate leads. Jain, K.K. Trends Biotechnol. (2002) [Pubmed]
  47. From molecular diagnostics to personalized medicine. The IBC Workshop, London, UK, 1st May, 2002. Jain, K.K. Expert Rev. Mol. Diagn. (2002) [Pubmed]
  48. Recent advances in oncoproteomics. Jain, K.K. Curr. Opin. Mol. Ther. (2002) [Pubmed]
  49. Stem cell technologies in regenerative medicine. Jain, K.K. Expert. Opin. Biol. Ther (2002) [Pubmed]
  50. Ethical and regulatory aspects of embryonic stem cell research. Jain, K.K. Expert. Opin. Biol. Ther (2002) [Pubmed]
  51. Current trends in molecular diagnostics. Jain, K.K. Med. Device. Technol (2002) [Pubmed]
  52. New routes for drug discovery. Jain, K.K. Drug Discov. Today (2002) [Pubmed]
  53. Personalized medicine. Jain, K.K. Curr. Opin. Mol. Ther. (2002) [Pubmed]
  54. Proteomics-based anticancer drug discovery and development. Jain, K.K. Technol. Cancer Res. Treat. (2002) [Pubmed]
  55. Role of proteomics in diagnosis of cancer. Jain, K.K. Technol. Cancer Res. Treat. (2002) [Pubmed]
  56. Cambridge Healthtech Institute's Third Annual Conference on Lab-on-a-Chip and Microarrays. 22-24 January 2001, Zurich, Switzerland. Jain, K.K. Pharmacogenomics (2001) [Pubmed]
  57. Applied neurogenomics. Jain, K.K. Pharmacogenomics (2001) [Pubmed]
  58. Use of bacteria as anticancer agents. Jain, K.K. Expert. Opin. Biol. Ther (2001) [Pubmed]
  59. Will neurogenomics revolutionize neurotherapeutics?. Jain, K. Expert. Rev. Neurother (2001) [Pubmed]
  60. Biotechnological applications of lab-chips and microarrays. Jain, K.K. Trends Biotechnol. (2000) [Pubmed]
  61. Neuroprotection in cerebrovascular disease. Jain, K.K. Expert. Opin. Investig. Drugs (2000) [Pubmed]
  62. An assessment of rufinamide as an anti-epileptic in comparison with other drugs in clinical development. Jain, K.K. Expert. Opin. Investig. Drugs (2000) [Pubmed]
  63. Nicaraven for the treatment of cerebral vasospasm in subarachnoid haemorrhage. Jain, K.K. Expert. Opin. Investig. Drugs (2000) [Pubmed]
  64. Evaluation of mitoxantrone for the treatment of multiple sclerosis. Jain, K.K. Expert. Opin. Investig. Drugs (2000) [Pubmed]
  65. Evaluation of memantine for neuroprotection in dementia. Jain, K.K. Expert. Opin. Investig. Drugs (2000) [Pubmed]
  66. An assessment of levetiracetam as an anti-epileptic drug. Jain, K.K. Expert. Opin. Investig. Drugs (2000) [Pubmed]
  67. An evaluation of intrathecal ziconotide for the treatment of chronic pain. Jain, K.K. Expert. Opin. Investig. Drugs (2000) [Pubmed]
  68. Evaluation of intravenous parecoxib for the relief of acute post-surgical pain. Jain, K.K. Expert. Opin. Investig. Drugs (2000) [Pubmed]
  69. An assessment of iloperidone for the treatment of schizophrenia. Jain, K.K. Expert. Opin. Investig. Drugs (2000) [Pubmed]
  70. An assessment of zonisamide as an anti-epileptic drug. Jain, K.K. Expert. Opin. Pharmacother (2000) [Pubmed]
  71. Applications of biochip and microarray systems in pharmacogenomics. Jain, K.K. Pharmacogenomics (2000) [Pubmed]
  72. Applications of proteomics in oncology. Jain, K.K. Pharmacogenomics (2000) [Pubmed]
WikiGenes - Universities